View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Join NSF’s Robyn Meurant and Rachel Carmichael at MMPathIC Event on 23 September

The Manchester Molecular Pathology Innovation Centre (MMPathIC), in collaboration with the Diagnostics and Technology Accelerator (DiTA) and NIHR Manchester Biomedical Research Center, is hosting a workshop on the 23 September at the Manchester Science Partnership Citylabs.

This one-day event, focusing on the regulatory requirements for IVDs and medical devices, will be attended by NSF’s Robyn Meurant and Rachel Carmichael.

Understanding the regulatory route to market is key for successful commercialisation. This workshop aims to give participants an overview of diagnostic test development, from the feasibility and patenting stages, to the regulatory considerations one needs to be aware of if aiming for eventual uptake in the clinic.

Robyn Meurant, Executive Director, Regulatory Team, IVDs and Medical Devices, will start the workshop with an introduction to regulatory requirements for EU medical devices and IVDs. She will discuss critical aspects, including new requirements for clinical evidence, post-market surveillance and economic operators (distributors, importers, etc.).

Rachel Carmichael, Executive Director, Pharmaceutical Services, will be discussing effective GxP data integrity governance, a matter of high importance for any device manufacturer.

This workshop is designed to be accessible to anyone, however places are limited, so please fill out the enquiry form on this page for more information on how to attend.

NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology